Russell Investments Group, Ltd.

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1692234 Seattle, WA

Position in DNA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$373,595

+$232,025 QoQ

Shares Held

37,699

+63.2% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#70

of 183 holders

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. DNA ranks #161 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$373,595	37,699	+63.2%	Shares	Defined	2026-08-06
2026-03-31	$141,570	23,095	+3.1%	Shares	Other	2026-05-08
2025-12-31	$186,200	22,407	+4.6%	Shares	Other	2026-02-17
2025-09-30	$312,228	21,415	+174.6%	Shares	Defined	2025-11-13
2024-09-30	$63,569	7,800	-90.5%	Shares	Sole	2024-11-13
2024-06-30	$27,495	82,322	+157.6%	Shares	Defined	2024-08-08
2024-03-31	$37,074	31,961	+9440.6%	Shares	Defined	2024-05-08
2023-12-31	$566	335	+92.5%	Shares	Defined	2024-02-05
2023-09-30	$314	174	-100.0%	Shares	Defined	2023-11-13
2023-06-30	$772,011	415,060	-61.2%	Shares	Defined	2023-08-10
2023-03-31	$1,421,376	1,068,705	+3386.5%	Shares	Defined	2023-05-09
2022-12-31	$51,803	30,653	0.0%	Shares	Defined	2023-02-08
2022-09-30	$95,637	30,653	+54.3%	Shares	Defined	2022-11-04
2022-06-30	$47,281	19,866	—	Shares	Defined	2022-07-29
No filing history on record for this holder in this stock.